63 results
8-K
JAZZ
Jazz Pharmaceuticals plc
21 Feb 24
Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer
7:46am
and the Severance Plan, see “Executive Compensation” under Part III, Item 11 in Amendment No. 1 to the Company’s Annual Report on Form 10-K/A, filed with the U.S
DEFA14A
mkvz2hik
14 Jul 21
Additional proxy soliciting materials
4:57pm
8-K
j58fvsqsja5i316
5 May 21
Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc
4:10pm